Olema Pharmaceuticals (OLMA) Change in Acquisitions & Divestments (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $74.5 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $74.5 million, down 23.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $321.7 million (down 6.29% YoY), and the FY2025 annual result was $345.0 million, up 14.38% from the prior year.
• Change in Acquisitions & Divestments fell to $74.5 million in Q1 2026 per OLMA's latest filing, from $91.2 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $148.8 million in Q1 2022 and troughed at $38.8 million in Q3 2022.
• A 5-year average of $75.1 million and a median of $70.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 14775.0% in 2022 and fell as far as 67.56% in 2022.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $61.0 million in 2022, then declined by 11.48% to $54.0 million in 2023, then jumped by 38.53% to $74.8 million in 2024, then gained by 21.87% to $91.2 million in 2025, then slipped by 18.32% to $74.5 million in 2026.
• Business Quant data shows OLMA's Change in Acquisitions & Divestments at $74.5 million in Q1 2026, $91.2 million in Q4 2025, and $88.9 million in Q3 2025.